• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医证候分类与结直肠癌肿瘤细胞和微环境异质性的关联:单细胞RNA测序分析

Traditional chinese medicine syndromes classification associates with tumor cell and microenvironment heterogeneity in colorectal cancer: a single cell RNA sequencing analysis.

作者信息

Lu Yiyu, Zhou Chungen, Zhu Meidong, Fu Zhiliang, Shi Yong, Li Min, Wang Wenhai, Zhu Shibo, Jiang Bin, Luo Yunquan, Su Shibing

机构信息

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Department of Anorectal, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210001, China.

出版信息

Chin Med. 2021 Dec 7;16(1):133. doi: 10.1186/s13020-021-00547-7.

DOI:10.1186/s13020-021-00547-7
PMID:34876190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8650518/
Abstract

BACKGROUND

Colorectal cancer (CRC) is one of the common gastrointestinal malignancies, tumor heterogeneity is the main cause of refractory CRC. Syndrome differentiation is the premise of individualized treatment of traditional Chinese medicine (TCM), but TCM syndrome lacks objective identification in CRC. This study is to investigate the correlation and significance of tumor heterogeneity and TCM syndromes classification in CRC.

METHODS

In this study, we using scRNA-seq technology, investigate the significance of tumor heterogeneity in TCM syndromes classification on CRC.

RESULTS

The results showed that 662 cells isolated from 11 primary CRC tumors are divided into 14 different cell clusters, and each cell subtype and its genes have different functions and signal transduction pathways, indicating significant heterogeneity. CRC tumor cell clusters have different proportions in Excess, Deficiency and Deficiency-Excess syndromes, and have their own characteristic genes, gene co-expression networks, gene functional interpretations as well as monocle functional evolution. Moreover, there were significant differences between the high expressions of MUC2, REG4, COL1A2, POSTN, SDPR, GPX1, ELF3, KRT8, KRT18, KRT19, FN1, SERPINE1, TCF4 and ZEB1 genes in Excess and Deficiency syndrome classification in CRC (P < 0.01).

CONCLUSIONS

The Excess and Deficiency syndromes classification may be related to tumor heterogeneity and its microenvironment in CRC.

摘要

背景

结直肠癌(CRC)是常见的胃肠道恶性肿瘤之一,肿瘤异质性是难治性CRC的主要原因。辨证是中医个体化治疗的前提,但中医证候在CRC中缺乏客观识别。本研究旨在探讨CRC中肿瘤异质性与中医证候分类的相关性及意义。

方法

在本研究中,我们使用单细胞RNA测序(scRNA-seq)技术,研究肿瘤异质性在CRC中医证候分类中的意义。

结果

结果显示,从11例原发性CRC肿瘤中分离出的662个细胞被分为14个不同的细胞簇,每个细胞亚型及其基因具有不同的功能和信号转导途径,表明存在显著的异质性。CRC肿瘤细胞簇在实证、虚证和虚实夹杂证中的比例不同,且有各自的特征基因、基因共表达网络、基因功能诠释以及单细胞功能进化。此外,CRC实证和虚证分类中MUC2、REG4、COL1A2、POSTN、SDPR、GPX1、ELF3、KRT8、KRT18、KRT19、FN1、SERPINE1、TCF4和ZEB1基因高表达之间存在显著差异(P < 0.01)。

结论

实证和虚证分类可能与CRC中的肿瘤异质性及其微环境有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/6c7b203576f6/13020_2021_547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/7c151e00efef/13020_2021_547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/19aeaba56b7c/13020_2021_547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/a36e21b15ff6/13020_2021_547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/175219a2d5c7/13020_2021_547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/6c7b203576f6/13020_2021_547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/7c151e00efef/13020_2021_547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/19aeaba56b7c/13020_2021_547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/a36e21b15ff6/13020_2021_547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/175219a2d5c7/13020_2021_547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15f/8650518/6c7b203576f6/13020_2021_547_Fig5_HTML.jpg

相似文献

1
Traditional chinese medicine syndromes classification associates with tumor cell and microenvironment heterogeneity in colorectal cancer: a single cell RNA sequencing analysis.中医证候分类与结直肠癌肿瘤细胞和微环境异质性的关联:单细胞RNA测序分析
Chin Med. 2021 Dec 7;16(1):133. doi: 10.1186/s13020-021-00547-7.
2
Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes.比较不同中医证型结直肠癌患者免疫功能、血液流变学改变与预后的相关性分析
Cancer Biomark. 2018 Feb 14;21(3):701-710. doi: 10.3233/CBM-170805.
3
TCM syndrome differentiation in colorectal cancer patients assisted by differences in gut microbiota: An exploratory study.肠道微生物群差异辅助结直肠癌患者的中医辨证:一项探索性研究。
Heliyon. 2023 Oct 20;9(11):e21057. doi: 10.1016/j.heliyon.2023.e21057. eCollection 2023 Nov.
4
An exploratory study on TCM syndrome differentiation in preoperative patients with colorectal cancer assisted by laboratory indicators.一项借助实验室指标对结直肠癌术前患者进行中医辨证的探索性研究。
Heliyon. 2022 Aug 14;8(8):e10207. doi: 10.1016/j.heliyon.2022.e10207. eCollection 2022 Aug.
5
Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context.结直肠癌进展过程中的动态异质性在单细胞分辨率和空间背景下揭示了临床风险相关的细胞类型和调控。
Gastroenterol Rep (Oxf). 2023 Jun 24;11:goad034. doi: 10.1093/gastro/goad034. eCollection 2023.
6
Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment.单细胞测序技术在结直肠癌中的应用:揭示肿瘤异质性和精准治疗的新技术。
Front Immunol. 2023 May 15;14:1175343. doi: 10.3389/fimmu.2023.1175343. eCollection 2023.
7
Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis.基于 SELDI 技术的蛋白质芯片分析对慢性乙型肝炎中医证候的分类。
Evid Based Complement Alternat Med. 2012;2012:626320. doi: 10.1155/2012/626320. Epub 2012 May 30.
8
Single-Cell RNA Sequencing Analysis of the Heterogeneity in Gene Regulatory Networks in Colorectal Cancer.结直肠癌基因调控网络异质性的单细胞RNA测序分析
Front Cell Dev Biol. 2021 Nov 30;9:765578. doi: 10.3389/fcell.2021.765578. eCollection 2021.
9
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.单细胞转录组分析揭示结直肠癌肝转移瘤肿瘤免疫微环境异质性和粒细胞富集。
Cancer Lett. 2020 Feb 1;470:84-94. doi: 10.1016/j.canlet.2019.10.016. Epub 2019 Oct 11.
10
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.单细胞 RNA 测序在乳腺癌中的应用:解析肿瘤异质性并为个体化治疗铺平道路。
Cancer Commun (Lond). 2020 Aug;40(8):329-344. doi: 10.1002/cac2.12078. Epub 2020 Jul 12.

引用本文的文献

1
Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer.中医药在结直肠癌防治中的研究进展
World J Gastrointest Oncol. 2025 Jun 15;17(6):105690. doi: 10.4251/wjgo.v17.i6.105690.
2
Novel prognostic model of complement and coagulation cascade-related genes correlates with immune environment and drug sensitivity in hepatocellular carcinoma.补体和凝血级联相关基因的新型预后模型与肝细胞癌的免疫环境及药物敏感性相关。
Heliyon. 2024 Sep 20;10(19):e38230. doi: 10.1016/j.heliyon.2024.e38230. eCollection 2024 Oct 15.
3
Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment.

本文引用的文献

1
Single-cell RNA sequencing in cancer research.癌症研究中的单细胞RNA测序
J Exp Clin Cancer Res. 2021 Mar 1;40(1):81. doi: 10.1186/s13046-021-01874-1.
2
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.多区域单细胞测序揭示结直肠癌免疫微环境的转录景观。
Clin Transl Med. 2021 Jan;11(1):e253. doi: 10.1002/ctm2.253.
3
Keratin intermediate filaments in the colon: guardians of epithelial homeostasis.结肠中的角蛋白中间丝:上皮细胞稳态的守护者。
泛癌症分析 CDKN2A 改变鉴定出具有冷肿瘤免疫微环境的胃癌亚群。
Hum Genomics. 2024 May 31;18(1):55. doi: 10.1186/s40246-024-00615-7.
4
Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.中药及生物活性化合物对维生素D受体的调节作用:在维生素D受体依赖性疾病中的潜在治疗应用
Front Pharmacol. 2024 Jan 22;15:1298181. doi: 10.3389/fphar.2024.1298181. eCollection 2024.
5
Single-cell multi-omics in the study of digestive system cancers.单细胞多组学在消化系统癌症研究中的应用
Comput Struct Biotechnol J. 2023 Dec 12;23:431-445. doi: 10.1016/j.csbj.2023.12.007. eCollection 2024 Dec.
6
Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine.网络药理学:迈向基于人工智能的精准中医药。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad518.
7
Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review).靶向关键 RNA 甲基化酶改善结直肠癌化疗的疗效(综述)。
Int J Oncol. 2024 Feb;64(2). doi: 10.3892/ijo.2023.5605. Epub 2023 Dec 22.
8
Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers.胃肠道癌症中医证候生物学基础的研究进展
Heliyon. 2023 Oct 20;9(11):e20653. doi: 10.1016/j.heliyon.2023.e20653. eCollection 2023 Nov.
9
Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.基于网络药理学和分子对接的分析预测黄芩汤治疗结直肠癌的潜在机制
World J Clin Cases. 2023 Jul 6;11(19):4553-4566. doi: 10.12998/wjcc.v11.i19.4553.
10
The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives.单细胞 RNA 测序技术的发展与应用:进展与展望。
Int J Mol Sci. 2023 Feb 2;24(3):2943. doi: 10.3390/ijms24032943.
Int J Biochem Cell Biol. 2020 Dec;129:105878. doi: 10.1016/j.biocel.2020.105878. Epub 2020 Nov 2.
4
Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.通过整合生物信息学分析鉴定和验证与 COAD 患者生存和预后相关的三个关键基因。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20200141.
5
Systems biology approaches to measure and model phenotypic heterogeneity in cancer.用于测量和建模癌症表型异质性的系统生物学方法。
Curr Opin Syst Biol. 2019 Oct;17:35-40. doi: 10.1016/j.coisb.2019.09.002. Epub 2019 Sep 11.
6
Single Cell Transcriptome in Colorectal Cancer-Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells.结直肠癌中的单细胞转录组——其在转移、化疗耐药及循环肿瘤细胞作用方面的应用最新进展
Front Pharmacol. 2020 Feb 27;11:135. doi: 10.3389/fphar.2020.00135. eCollection 2020.
7
TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.TCF4 通过调控 ZEB1/ZEB2 的表达促进结直肠癌耐药和干性。
Protoplasma. 2020 May;257(3):921-930. doi: 10.1007/s00709-020-01480-6. Epub 2020 Jan 14.
8
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.单细胞转录组分析揭示结直肠癌肝转移瘤肿瘤免疫微环境异质性和粒细胞富集。
Cancer Lett. 2020 Feb 1;470:84-94. doi: 10.1016/j.canlet.2019.10.016. Epub 2019 Oct 11.
9
HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma.5-羟色胺受体1D、金属蛋白酶组织抑制因子1、丝氨酸蛋白酶抑制剂E1、基质金属蛋白酶3和大麻素受体2影响结肠腺癌患者的生存率。
Oncol Lett. 2019 Sep;18(3):2448-2454. doi: 10.3892/ol.2019.10545. Epub 2019 Jun 28.
10
Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer.单细胞转录谱分析揭示了结直肠癌的异质性。
Medicine (Baltimore). 2019 Aug;98(34):e16916. doi: 10.1097/MD.0000000000016916.